Internal Medicine, Hematology & Oncology · Newark, DE
NPI
1144450271
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
4701 Ogletown Stanton Rd, Ste 2400
Newark, DE, 19713
Phone (585) 975-9080
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
537 services
Medicare patients, 2024
338
Average age 74
Drug cost, 2024
$2.4M
1,469 prescriptions
Company payments, 2025
$755
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramya Varadarajan was code 99214 (office e&m - established), 237 times for 210 patients. In total Ramya Varadarajan billed 537 services in 11 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-09-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 237 | 210 | $66.76 | $16K |
| 99215 Office E&M - Established | Facility | 169 | 94 | $107.38 | $18K |
| 99204 Office E&M - New | Facility | 60 | 60 | $98.99 | $5,939 |
| 99205 Office E&M - New | Facility | 20 | 20 | $140.64 | $2,813 |
| 99213 Office E&M - Established | Facility | 19 | 19 | $42.94 | $816 |
By year: 2022 $80K for 1,418 services; 2023 $45K for 586 services; 2024 $46K for 537 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ramya Varadarajan prescribed most often to Medicare patients was Anastrozole, with 843 prescriptions and refills. In total Ramya Varadarajan wrote 1,469 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 843 | 2,456 | 312 | $26K |
| Alendronate Sodium Generic | 82 | 228 | 33 | $955 |
| Tamoxifen Citrate Generic | 74 | 207 | 32 | $2,980 |
| Letrozole Generic | 63 | 155 | 19 | $1,268 |
| Ibrance Palbociclib | 56 | 60 | Under 11 | $977K |
| Gabapentin Generic | 44 | 78 | 14 | $589 |
| Verzenio Abemaciclib | 38 | 38 | Under 11 | $587K |
| Exemestane Generic | 31 | 71 | Under 11 | $4,293 |
| Eliquis Apixaban | 18 | 25 | Under 11 | $14K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 17 | 29 | Under 11 | $228 |
| Oxycodone Hcl Generic | 13 | 13 | Under 11 | $184 |
| Hydroxyurea Generic | 12 | 22 | Under 11 | $329 |
| Tagrisso Osimertinib Mesylate | 12 | 12 | Under 11 | $203K |
| Orserdu Elacestrant Hcl | 11 | 11 | Under 11 | $252K |
| Lynparza Olaparib | 11 | 11 | Under 11 | $156K |
Brand drugs: - claims; generic drugs: 1,282 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramya Varadarajan $755 ($755 in general payments such as food, travel and fees) from 20 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $97.05.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $97.05 |
| Seagen Inc. PFE | 1 | $72.73 |
| Incyte Corporation INCY | 3 | $58.18 |
| Daiichi Sankyo Inc. 4568.T | 2 | $57.25 |
| BeOne Medicines USA, Inc. ONC | 2 | $54.29 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $47.08 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $39.91 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $33.38 |
| Merck Sharp & Dohme LLC MRK | 1 | $32.3 |
| Invivyd Inc IVVD | 1 | $31.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.